March 9, 2023 06:50 AM EST
Pharma
Manufacturing

Short sup­ply of com­mon­ly used can­cer drugs rais­es con­cerns among hos­pi­tal phar­ma­cists

Tyler Patchen

News Reporter

Ex­perts who track drug sup­ply and care for can­cer pa­tients say they are watch­ing with con­cern about short­ages of sev­er­al gener­ic drugs that are wide­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times